Description of Medical ServiceMeasurement of NT-proBNP (also known as N-terminal pro-brain natriuretic peptide, N-terminal pro-B-type natriuretic peptide or N-terminal prohormone of brain natriuretic peptide) through a blood test. The blood test is intended to enable the early detection of systemic sclerosis related pulmonary arterial hypertension, and be used as a regular assessment of pulmonary arterial hypertension disease progression.
Description of Medical ConditionSystemic sclerosis (scleroderma) is a multi-organ autoimmune disease characterised by vasculopathy (disease affecting blood vessels) and fibrosis (thickening and scarring of connective tissue). Patients with systemic sclerosis are at an increased risk of pulmonary arterial hypertension. Pulmonary arterial hypertension is characterised by increased pulmonary vascular resistance (resistance against blood flow), and may be idiopathic (arising from an unknown cause), or due to other underlying factors or disease associations such as connective tissue disease.
Reason for ApplicationNew MBS item
Medical Service TypeInvestigative technology
Previous Application Number/sNot Applicable
Application FormApplication Form (PDF 5357 KB)
Application Form (Word 11392 KB)
Consultation SurveyConsultation Survey (PDF 692 KB)
Consultation Survey (Word 72 KB)
PASC consultation closed
MSAC consultation input must be received by no later than Friday, 10 June 2022 for it to be considered by MSAC at its July 2022 meeting.
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process
PICO ConfirmationPICO Confirmation (PDF 2256 KB)
PICO Confirmation (Word 7761 KB)